VERTEX PHARMACEUTICALS INC / MA — Form 10-Q

Vertex adopted its 2026 Stock and Option Plan and a Non-Employee Director Deferred Compensation Plan (effective May 13, 2026). The exhibits present standard RSU award agreements (time-based and performance-based for employees and directors), non-statutory stock options for directors, and a director deferred compensation arrangement allowing directors to defer cash compensation and vested RSUs into deferred stock units with dividend equivalents. No specific dollar amounts, share counts, or individual grant details are disclosed in these template documents.